- Home
- OUST vs XERS Comparison
OUST vs XERS Comparison
Compare OUST & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUST
- XERS
- Stock Information
- Founded
- OUST 2015
- XERS 2005
- Country
- OUST United States
- XERS United States
- Employees
- OUST N/A
- XERS N/A
- Industry
- OUST Industrial Machinery/Components
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- OUST Technology
- XERS Health Care
- Exchange
- OUST Nasdaq
- XERS Nasdaq
- Market Cap
- OUST 1.1B
- XERS 1.3B
- IPO Year
- OUST N/A
- XERS 2018
- Fundamental
- Price
- OUST $30.92
- XERS $7.97
- Analyst Decision
- OUST Strong Buy
- XERS Strong Buy
- Analyst Count
- OUST 6
- XERS 7
- Target Price
- OUST $23.83
- XERS $8.00
- AVG Volume (30 Days)
- OUST 2.9M
- XERS 2.2M
- Earning Date
- OUST 11-06-2025
- XERS 11-07-2025
- Dividend Yield
- OUST N/A
- XERS N/A
- EPS Growth
- OUST N/A
- XERS N/A
- EPS
- OUST N/A
- XERS N/A
- Revenue
- OUST $125,848,000.00
- XERS $246,025,000.00
- Revenue This Year
- OUST $33.30
- XERS $43.89
- Revenue Next Year
- OUST $36.50
- XERS $20.40
- P/E Ratio
- OUST N/A
- XERS N/A
- Revenue Growth
- OUST 26.37
- XERS 35.62
- 52 Week Low
- OUST $6.34
- XERS $2.82
- 52 Week High
- OUST $36.25
- XERS $8.51
- Technical
- Relative Strength Index (RSI)
- OUST 52.90
- XERS 51.52
- Support Level
- OUST $27.53
- XERS $7.90
- Resistance Level
- OUST $34.27
- XERS $8.46
- Average True Range (ATR)
- OUST 2.36
- XERS 0.33
- MACD
- OUST -0.05
- XERS -0.05
- Stochastic Oscillator
- OUST 58.02
- XERS 31.65
About OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).